Donovan Joanne M.
Insider CIK 1644087 · CATB Chief Medical Officer · EWTX CMO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-13 | 2026-08-14 | 2,919 | $43.41 | $126.7K | 8,625 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-13 | 2026-08-14 | 2,919 | $43.41 | $126.7K | 8,625 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 21,094 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 32,500 | — | $0 | 32,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,035 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 18,066 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,839 | $43.78 | $124.3K | 15,227 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,779 | $43.71 | $121.5K | 12,448 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 104 | $44.43 | $4.6K | 12,344 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 800 | $44.52 | $35.6K | 11,544 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-14 | 32,500 | — | $0 | 32,500 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 21,094 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,563 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 800 | $44.52 | $35.6K | 11,544 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 104 | $44.43 | $4.6K | 12,344 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,779 | $43.71 | $121.5K | 12,448 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-08-12 | 2026-08-14 | 2,839 | $43.78 | $124.3K | 15,227 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 7,031 | — | $0 | 18,066 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-08-12 | 2026-08-14 | 5,781 | — | $0 | 11,035 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2026-08-12 | 2026-08-17 | 65,000 | — | $0 | 65,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-05-05 | 2026-05-05 | 50,000 | — | $0 | 75,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-05-05 | 2026-05-05 | 50,000 | $7.08 | $354.0K | 54,367 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-05-05 | 2026-05-05 | 50,000 | $38.57 | $1.93M | 4,367 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-05-04 | 2026-05-05 | 5,230 | $31.29 | $163.6K | 4,367 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-04-01 | 2026-04-02 | 28,662 | — | $0 | 125,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-04-01 | 2026-04-02 | 28,662 | $32.31 | $926.1K | 9,597 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-04-01 | 2026-04-02 | 28,662 | $7.08 | $202.9K | 38,259 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2026-03-31 | 2026-03-31 | 21,338 | — | $0 | 153,662 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2026-03-31 | 2026-03-31 | 21,338 | $7.08 | $151.1K | 30,935 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-03-31 | 2026-03-31 | 21,338 | $32.12 | $685.4K | 9,597 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-03-27 | 2026-03-30 | 6,735 | $30.98 | $208.7K | 9,597 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2026-03-27 | 2026-03-30 | 9,623 | $30.98 | $298.1K | 16,332 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 17,344 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 168,750 | — | $0 | 168,750 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 28,125 | — | $0 | 28,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 28,223 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-08-12 | 2025-08-14 | 2,862 | $13.39 | $38.3K | 25,361 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-05-02 | 2025-05-07 | 5,187 | $16.45 | $85.3K | 21,588 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-05-01 | 2025-05-07 | 10,417 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-05-01 | 2025-05-07 | 10,417 | — | $0 | 26,775 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-01-28 | 2025-01-30 | 25,000 | — | $0 | 175,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-01-28 | 2025-01-30 | 25,000 | $27.63 | $690.8K | 16,358 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-01-28 | 2025-01-30 | 25,000 | $7.08 | $177.0K | 41,358 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 7,162 | $28.29 | $202.6K | 14,538 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 23,125 | — | $0 | 23,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 138,750 | — | $0 | 138,750 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-05-02 | 2024-05-03 | 3,682 | $18.91 | $69.6K | 19,897 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-05-01 | 2024-05-03 | 10,417 | — | $0 | 10,417 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-05-01 | 2024-05-03 | 10,417 | — | $0 | 23,579 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2023-08-17 | 2023-08-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2023-05-02 | 2023-05-03 | 3,254 | $8.90 | $29.0K | 9,960 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2023-05-01 | 2023-05-03 | 10,416 | — | $0 | 20,834 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2023-05-01 | 2023-05-03 | 10,416 | — | $0 | 13,214 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-08-08 | 2022-08-10 | 240,000 | — | $0 | 240,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-05-01 | 2022-05-03 | 31,250 | — | $0 | 31,250 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2021-08-17 | 2021-08-19 | 160,000 | — | $0 | 160,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2021-04-30 | 2021-05-04 | 160,000 | — | $0 | 160,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2020-02-12 | 2020-02-14 | 60,000 | — | $0 | 60,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2019-02-13 | 2019-02-15 | 40,000 | — | $0 | 40,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-09-07 | 2018-09-11 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2018-02-08 | 2018-02-09 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2017-02-09 | 2017-02-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-09-08 | 2016-09-12 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-09-08 | 2016-09-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | A Award deriv | 2016-02-11 | 2016-02-16 | 66,000 | — | $0 | 66,000 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 5,261 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 409 | — | $0 | 409 | SEC↗ |